[go: up one dir, main page]

WO2007108001A3 - Ligament remodeling - Google Patents

Ligament remodeling Download PDF

Info

Publication number
WO2007108001A3
WO2007108001A3 PCT/IL2007/000378 IL2007000378W WO2007108001A3 WO 2007108001 A3 WO2007108001 A3 WO 2007108001A3 IL 2007000378 W IL2007000378 W IL 2007000378W WO 2007108001 A3 WO2007108001 A3 WO 2007108001A3
Authority
WO
WIPO (PCT)
Prior art keywords
remodeling
ligament remodeling
ligament
conforms
diluents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2007/000378
Other languages
French (fr)
Other versions
WO2007108001A2 (en
Inventor
Haim Dror Blecher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2007108001A2 publication Critical patent/WO2007108001A2/en
Publication of WO2007108001A3 publication Critical patent/WO2007108001A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0078—Ultrasound therapy with multiple treatment transducers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Electromagnetism (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition comprising an active ingredient including a physiologically effective amount of a remodeling agent capable of altering properties of a Ligamentum Flavum (LF) so that the LF conforms to an available dimension of a spinal canal; and a pharmaceutically acceptable carrier, diluents and excipients.
PCT/IL2007/000378 2006-03-22 2007-03-22 Ligament remodeling Ceased WO2007108001A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78456106P 2006-03-22 2006-03-22
US60/784,561 2006-03-22

Publications (2)

Publication Number Publication Date
WO2007108001A2 WO2007108001A2 (en) 2007-09-27
WO2007108001A3 true WO2007108001A3 (en) 2007-12-06

Family

ID=38481926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2007/000378 Ceased WO2007108001A2 (en) 2006-03-22 2007-03-22 Ligament remodeling

Country Status (1)

Country Link
WO (1) WO2007108001A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037296A1 (en) * 1998-01-23 1999-07-29 Warner-Lambert Company Gabapentin and its derivatives for the treatment of muscular and skeletal pain
US6684886B1 (en) * 2000-01-21 2004-02-03 Prospine, Inc. Intervertebral disc repair methods and apparatus
JP2004331612A (en) * 2003-05-09 2004-11-25 Koyo Chemical Kk Medicament for improving dysbasia intermittens by lumbar spinal canal stenosis
WO2006044727A2 (en) * 2004-10-15 2006-04-27 Baxano, Inc. Devices and methods for tissue removal

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037296A1 (en) * 1998-01-23 1999-07-29 Warner-Lambert Company Gabapentin and its derivatives for the treatment of muscular and skeletal pain
US6684886B1 (en) * 2000-01-21 2004-02-03 Prospine, Inc. Intervertebral disc repair methods and apparatus
JP2004331612A (en) * 2003-05-09 2004-11-25 Koyo Chemical Kk Medicament for improving dysbasia intermittens by lumbar spinal canal stenosis
WO2006044727A2 (en) * 2004-10-15 2006-04-27 Baxano, Inc. Devices and methods for tissue removal

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200481, Derwent World Patents Index; AN 2004-817460, XP002453291 *
KIMURA S ET AL: "Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain reliefin relief in degenerative lumbar diseases", PAIN, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 92, no. 3, 2001, pages 363 - 371, XP002975869, ISSN: 0304-3959 *

Also Published As

Publication number Publication date
WO2007108001A2 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
MX2009003038A (en) 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same.
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
TWI366460B (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
MX2009004861A (en) Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor.
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
JO2973B1 (en) Fumarate Salt Of (alphaS, betaR)-6-Bromo-alfa-[2-(dimethylamino)ethyl]-2- Methoxy-alpha-1-naphthalenyl-beta-phenyl-3- Quinolineethanol
UA94065C2 (en) Dihydropseudoerythromycin derivatives
WO2008136392A1 (en) Preparation for oral administration
EP2316420A8 (en) Method to reduce pain
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2008004100A3 (en) Therapeutic compounds
WO2010029093A3 (en) Compositions for percutaneous administration
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
MX2009005329A (en) Anticonvulsive pharmaceutical compositions.
MY144613A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same
UA95274C2 (en) Solid pharmaceutical composition comprising irbesartan and processes for the manufacture thereof
WO2009108017A3 (en) New pyruvate derivatives with neuroprotective effect, process for preparing the same and pharmaceutical composition comprising the same
WO2007108001A3 (en) Ligament remodeling
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
AU2016219606A1 (en) Pharmaceutical composition for treating or preventing burn injuries
WO2007047881A3 (en) Method for treating neuropathic pain

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07713394

Country of ref document: EP

Kind code of ref document: A2